Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
Recruiting
N/A
Interventional Study
ENDOMETRIAL CANCER
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 278 (estimated)
- Sponsor
- Anthony Costales, MD · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This is a prospective, multi-center, randomized non-inferiority phase III study to evaluate if patients undergoing a minimally invasive surgery for early stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus patients who do not have a uterine manipulator placed.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
A subject will be considered eligible for inclusion in this study if all the following criteria are met:
1. Patient must be greater than or equal to 18 years old.
2. Suspected clinically early stage endometrial cancer of any histology (endometrioid, mixed, serous, clear-cell, c…
Contacts